Suppr超能文献

皮肤癌疾病风险评分。

Disease risk scores for skin cancers.

机构信息

23andMe Inc., 223N Mathilda Ave, Sunnyvale, CA, 94086, USA.

出版信息

Nat Commun. 2021 Jan 8;12(1):160. doi: 10.1038/s41467-020-20246-5.

Abstract

We trained and validated risk prediction models for the three major types of skin cancer- basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma-on a cross-sectional and longitudinal dataset of 210,000 consented research participants who responded to an online survey covering personal and family history of skin cancer, skin susceptibility, and UV exposure. We developed a primary disease risk score (DRS) that combined all 32 identified genetic and non-genetic risk factors. Top percentile DRS was associated with an up to 13-fold increase (odds ratio per standard deviation increase >2.5) in the risk of developing skin cancer relative to the middle DRS percentile. To derive lifetime risk trajectories for the three skin cancers, we developed a second and age independent disease score, called DRSA. Using incident cases, we demonstrated that DRSA could be used in early detection programs for identifying high risk asymptotic individuals, and predicting when they are likely to develop skin cancer. High DRSA scores were not only associated with earlier disease diagnosis (by up to 14 years), but also with more severe and recurrent forms of skin cancer.

摘要

我们在一个包含 21 万名同意参与在线调查的研究参与者的横断面和纵向数据集中,对三种主要皮肤癌(基底细胞癌(BCC)、鳞状细胞癌(SCC)和黑色素瘤)进行了风险预测模型的训练和验证,该调查涵盖了皮肤癌的个人和家族史、皮肤敏感性和紫外线暴露等情况。我们开发了一个主要疾病风险评分(DRS),该评分结合了 32 个已确定的遗传和非遗传风险因素。最高百分位的 DRS 与发展皮肤癌的风险增加了 13 倍(每增加一个标准差的比值大于 2.5),与中间 DRS 百分位相比。为了得出三种皮肤癌的终生风险轨迹,我们开发了第二个与年龄无关的疾病评分,称为 DRSA。通过发病病例,我们证明 DRSA 可用于早期检测计划,以识别高风险的渐近个体,并预测他们可能患上皮肤癌的时间。高 DRSA 评分不仅与更早的疾病诊断(最多提前 14 年)有关,还与更严重和更频繁的皮肤癌形式有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b6/7794415/6264db9dede7/41467_2020_20246_Fig2_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验